Editas, Allergan open first trial of in vivo CRISPR therapy
One of the four sites of the trial, in a rare form of inherited blindness, is currently listed as open for enrollment, and the companies plan to dose the first patient soon.
Editas to deploy CRISPR therapy in humans by 2017
Looks like CRISPR is headed to the clinic: Editas Medicine just announced that it'll bring this gene editing technology to human trials by 2017.
Health Executives on Digital Transformation in Healthcare
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.